Formation of Calcified Nodule as a Cause of Early In-Stent Restenosis in Patients Undergoing Dialysis
Open Access
- 20 October 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Heart Association
- Vol. 9 (19)
- https://doi.org/10.1161/JAHA.120.016595
Abstract
Background Dialysis is an independent risk factor for in-stent restenosis (ISR) after stent implantation in coronary arteries. However, the characteristics of ISR in patients undergoing dialysis remain unclear, as there are no histological studies evaluating the causes of this condition. The aim of the present study was to investigate the causes of ISR between patients who are undergoing dialysis and those who are not by evaluating tissues obtained from ISR lesions using directional coronary atherectomy. Methods and Results A total of 29 ISR lesions from 29 patients included in a multicenter directional coronary atherectomy registry of 128 patients were selected for analysis and divided into a dialysis group (n=8) and a nondialysis group (n=21). Histopathological evaluation demonstrated that an in-stent calcified nodule was a major histological characteristic of ISR lesions in the dialysis group and the prevalence of an in-stent calcified nodule was significantly higher in the dialysis group compared with the nondialysis group (75% versus 5%, respectively;P<0.01). On the other hand, the prevalence of an in-stent lipid-rich plaque was significantly lower in the dialysis group compared with the nondialysis group (0% versus 43%, respectively;P=0.03). In all cases with an in-stent calcified nodule, the underlying calcification before stent implantation was moderate to severe. When tissue characteristics were stratified according to duration post-stent implantation, an in-stent calcified nodule in the dialysis group was mainly observed within 1 year after stent implantation. Conclusions In-stent calcified nodules are a common cause of ISR in patients undergoing dialysis and are observed within 1 year after stent implantation, suggesting different causes of ISR between patients undergoing dialysis and those who are not.This publication has 40 references indexed in Scilit:
- The Pathology of Neoatherosclerosis in Human Coronary Implants: Bare-Metal and Drug-Eluting StentsJournal of the American College of Cardiology, 2011
- Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: insights from the Japan multi-centre post-marketing surveillance registryEuropean Heart Journal, 2010
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Directional coronary atherectomy: a time for reflection. Should we let it go?EuroIntervention, 2009
- Assessment of Sirolimus-Eluting Coronary Stent Implantation With Aspirin Plus Low Dose Ticlopidine Administration One Year Results From CYPHER Stent Japan Post-Marketing Surveillance Registry (J-PMS)Circulation Journal, 2009
- Impact of Renal Function on Coronary Plaque Morphology and Morphometry in Patients With Chronic Renal Insufficiency as Determined by Intravascular Ultrasound Volumetric AnalysisThe American Journal of Cardiology, 2005
- Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing HemodialysisThe New England Journal of Medicine, 2005
- Kidney Disease as a Risk Factor for Development of Cardiovascular DiseaseHypertension, 2003
- Neutrophil Infiltration of Culprit Lesions in Acute Coronary SyndromesCirculation, 2002
- Directional atherectomy for treatment of restenosis within coronary stents: Clinical, angiographic and histologic resultsJournal of the American College of Cardiology, 1992